Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

NAMHC Minutes of the 272nd Meeting

January 29 and January 30, 2024

Department of Health and Human Services
Public Health Service
National Institutes of Health
National Advisory Mental Health Council

Introduction

The National Advisory Mental Health Council (NAMHC) held its 272nd meeting at 12:30 pm, January 29, 2024, via Zoom and National Institutes of Health (NIH) videocast. In accordance with Public Law 92-463, the session was open to the public until approximately 4:15 pm and was preceded by the closed session on January 30, 2024. Joshua Gordon, M.D., Ph.D., Director of the National Institute of Mental Health (NIMH), presided as Chair for both sessions.

Council Members Present

  • Edwin (Ted) Abel, III, Ph.D.
  • Olusola Ajilore, M.D., Ph.D.
  • Rinad Beidas, Ph.D.
  • Pamela Collins, M.D., M.P.H.
  • Daniel Gillison, Jr.
  • Marguerita Lightfoot, Ph.D.
  • Angus MacDonald, III, Ph.D.
  • Velma McBride Murry, Ph.D.
  • Joel Nigg, Ph.D.
  • Matthew Nock, Ph.D.
  • Jyotishman Pathak, Ph.D.
  • Bryan Roth, M.D., Ph.D.
  • Laura Scott, Ph.D., M.P.H.
  • Joseph Telfair, DrPH, M.P.H.
  • Hongkui Zeng, Ph.D.

Council Members Absent

  • Patricia Recupero, M.D., J.D.

Department of Veteran Affairs (Ex Officio Member)

  • Amy Kilbourne, Ph.D., M.P.H.

Liaison Representative (Ex Officio Member)

  • Anita Everett, M.D., DFAPA

Others present at Open Policy Session (Appendix B)

Others present at Closed Grant Review Session (Appendix C)

OPEN PORTION OF THE MEETING

  1. Open Policy Session Call to Order & Opening Remarks, Joshua Gordon, M.D., Ph.D. (NIH Videocast  @00:16)

    NIMH Director Dr. Joshua Gordon opened the virtual NAMHC meeting and welcomed Council members, NIMH staff, NIH staff, and members of the public. Following a review of virtual meeting etiquette, the Council unanimously passed a motion approving the final Summary Minutes of the September 2023 meeting.

  2. NIMH Director’s Report, Joshua Gordon, M.D., Ph.D. (NIH Videocast  @05:15)
    1. Congressional Interactions

      Dr. Gordon briefly reviewed NIMH senior staff participation in several congressional briefings on topics such as youth mental health, including the impacts of social media, and the anticipated renewal of the Autism CARES Act in summer 2024.

    2. Appropriations and Budget Updates

      On January 18, 2024, Congress passed a continuing resolution that funded NIH through March 8, 2024. Congress also announced an agreement on fiscal year (FY) 2024 topline funding levels, including $772.7 billion for nondefense programs, and was negotiating funding levels for 12 appropriation bills.

    3. HHS and NIH Updates

      HHS awarded more than $103 million to expand access to maternal health care and more than $230 million in grants for suicide prevention and behavioral health care for marginalized communities. In September 2023, the Interagency Autism Coordinating Committee (IACC) released the 2021-2023 Strategic Plan for Autism Research, Services, and Policy , and in December 2023, the IACC published the 2022 IACC Summary of Advances in Autism Research . The NIMH Office of National Autism Coordination issued a request for information  to help identify priorities related to co-occurring conditions in autism.

      On September 26, 2023, the Director of the National Institute on Minority Health and Health Disparities (NIMHD), Eliseo Pérez-Stable, M.D., designated people with disabilities  as a population with health disparities. Dr. Gordon said that NIMH supported this designation and looked forward to working with NIMHD on reducing disparities in this population. On December 14, 2023, President Joe Biden visited the NIH Clinical Center, met with NIH Director Monica Bertagnolli, M.D., and announced a plan to reduce the costs of prescription drugs . On October 25, 2023, First Lady Jill Biden, Ed.D., and Jodie Haydon, the partner of the Prime Minister of Australia, visited NIH  and met with National Cancer Institute (NCI) researchers to discuss research collaborations.

      Dr. Gordon reviewed NIH leadership transitions, including the appointments of Dr. Bertagnolli as the 17th Director of NIH; W. Kimryn Rathmell, M.D., Ph.D., as the 16th Director of NCI; Lyric Jorgenson, Ph.D., as NIH Associate Director for Science Policy; Tara Schwetz, Ph.D., as NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives; and Katherine Klimczak, M.P.P., as NIH Associate Director for Legislative Policy and Analysis and Director of the NIH Office of Legislative Policy and Analysis.

      NIH made 26 awards totaling approximately $171 million over five years under the Community Partnerships to Advance Science for Society (ComPASS) Program , which is supporting interventions targeting social determinants of health, aimed at structural and community levels. On September 29, 2023, the NIH All of Us Research Program partnered with the National Institute on Drug Abuse to host a webinar  on how to use the All of Us Researcher Workbench . All of Us also awarded $30 million to establish the Center for Linkage and Acquisition of Data . On September 26, 2023, The Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative  launched its third transformative project, the BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS) .

    4. NIMH News to Know 

      Dr. Gordon described the success of the NIMH 75th Anniversary Kickoff Event  and encouraged the community to review the NIMH 75th Anniversary website to learn more about upcoming events and resources. Lisa Bowleg, Ph.D., M.A., received the 2023 James Jackson Memorial Award for her research on social-structural and behavioral factors that impact the mental health of Black men in the United States. The newly established Division of Data Science and Technology will be led by Director Greg Farber, Ph.D., and Deputy Director Ruben Alvarez, Ed.D. Additionally, Gregory Greenwood, Ph.D., M.P.H., was named Deputy Director of the Division of AIDS Research. Dr. Gordon announced the passing of Sean Marrett, Ph.D., who served in the Intramural Research Program’s Functional MRI Facility. He also announced the retirement of Ann Huston, M.P.A., from her position as Deputy Director of Management/Executive Officer, effective February 2024.

    5. Science Highlights

      Dr. Gordon shared three science highlights. The first study1 aimed to replicate the NIMH-funded AURORA study, which found that brain-based biotypes could predict the likelihood of developing anxiety and post-traumatic stress disorder (PTSD) in the aftermath of exposure to a traumatic event. The new study did not replicate these findings, emphasizing the need for robust techniques, technologies, and approaches with large datasets to ensure generalizability across populations.

      The second study2 looked at a large group of individuals with psychosis in inpatient settings to determine whether an acceptance and commitment therapy intervention could improve adherence to treatment after hospitalization and reduce the risk of re-hospitalization. They found that individuals receiving the intervention did show improvements in the six months after the treatment condition, which was an important finding for treatment in real-world settings.

      The third study3 used a rodent model to investigate the role of dynorphin and kappa-opioid receptors in information processing in the medial prefrontal cortex (mPFC). They found that dynorphin can change mPFC activity by regulating the input the mPFC receives from other brain regions. These findings suggest that dynorphin may be a target for treating conditions characterized by dysregulation in the mPFC.

      Discussion
      Following Dr. Gordon’s update, Council members engaged in a discussion. One Council member asked about where technology development fits with the establishment of DST, and Dr. Gordon clarified that this research will remain within DST’s research portfolio. Council members asked for clarification on the types of research Congress was interested in. Dr. Gordon responded that Congress specifically expressed interest in research on the impact of social media on children and adolescents, as well as research that supports systems-based, public health perspectives. Council members also asked about the impact of the decreased 21st Century Cures Act appropriations. Dr. Gordon noted its potential impact on the BRAIN Initiative. Another Council member asked about the future of the ComPASS program. Dr. Gordon described that the ComPASS program’s first five years are focused on intervention research planning and piloting. ComPASS anticipates funding another five years for full-scale intervention trials, as well as additional funding for another round of awards. Lastly, a Council member asked about how NIMH is involved in the maternal health outcomes initiative, given that many of the efforts are being led by other HHS agencies. Dr. Gordon stated that NIMH staff have been working with other federal agencies to advise on evidence-based mental health practices that will support their efforts as part of this initiative.

  3. Introducing the Advanced Research Projects Agency for Health (ARPA-H), Susan Monarez, Ph.D., Deputy Director, ARPA-H, (NIH Videocast  @55:01)

    Dr. Gordon facilitated a question-and-answer session with Dr. Monarez.

    Question: What is the mission of ARPA-H and what has it accomplished in its first 18 months?

    Answer: ARPA-H invests in projects that are high-risk, high-reward across the health ecosystem rather than projects that create incremental improvements. While ARPA-H’s first six months were focused on developing operations and processes, ARPA-H had since executed more than $1 billion in funding across several initiatives, such as cancer diagnostics and treatment, mobile health units that can adapt to the unique needs of rural areas, and alternatives to organ transplants. ARPA-H aims to navigate between traditional knowledge building processes and innovative and accelerated processes that have a direct impact on patients. Data interoperability was one priority area that they would like to see accelerated into near real-time diagnostics and clinical next steps.

    Question: How does ARPA-H work with NIH?

    Answer: ARPA-H regularly communicates with NIH institutes and centers to ensure that their projects were complementary to and built from knowledge from the NIH portfolio. They also conduct extensive stakeholder outreach to ensure that they understand gaps from patient and provider perspectives. This helps ensure that any disruptive high-risk, high-reward approach is conducted with expert guidance. Another potential interaction between ARPA-H and NIH is data integration and interoperability. NIH holds robust repositories of data that can be translated into knowledge and have the potential to accelerate programmatic decision-making, design, and outcomes. ARPA-H also aims to ensure that data generated from their investments are publicly available. Dr. Monarez emphasized the importance of balancing the tension between data that required further validation to be meaningful and data that is not held back from supporting accelerated innovation.

    Question: How does ARPA-H identify its topics of interest?

    Answer: ARPA-H utilizes a program manager-centric model in which an individual can propose a program representing a major gap and a unique approach not already supported by other funding mechanisms. ARPA-H evaluates potential program managers carefully, then provides them with a budget over three years to execute their vision. ARPA-H also has a more traditional open solicitation for ideas that come from their external stakeholders. Dr. Monarez noted that ARPA-H does not currently have a program manager in behavioral health. Although there have been several behavioral health proposals, none have yet represented the type of program they would like to fund. There are a number of behavioral health challenges, such as the need for meaningful diagnostic categories, that ARPA-H would like to address.

    Question: Does ARPA-H support implementation science?

    Answer: ARPA-H is not in a position to support implementation science within their current portfolio, but hope to in the future.

  4. NIMH Special Council Review Policy Update, Susan Koester, Ph.D., Deputy Director, Division of Neuroscience and Basic Behavioral Science (NIH Videocast  @01:39:05)

    Dr. Koester reviewed the history of Special Council Review (SCR), which was implemented to more effectively manage resources. In 2022, NIMH revised SCR criteria for applications from very well-funded investigators. In 2023, Dr. Gordon challenged NIMH staff to consider whether there could be a more effective distribution of NIMH resources. NIMH formed an internal SCR committee to examine the impact of the current SCR criteria on the NIMH funding portfolio and proposed two revisions to the criteria. First, the committee felt that an “exceptional” score alone was not adequate justification for recommending additional funding and should only be considered when coupled with an application in a high priority research area. Second, the committee suggested revising the criteria for all principal investigators in the application to meet a $2 million threshold to any principal investigator. NIMH planned to issue a revised notice to clarify these changes. Dr. Gordon asked Council for feedback.

    Discussion
    Council members discussed concerns about junior investigators inadvertently losing their Early Stage Investigator (ESI) status when joining a Multiple Principal Investigators (MPI) application, the potential for a power imbalance, and the need to understand whether junior investigators who were part of an MPI grant eventually moved forward with their own funding. The Council unanimously passed a motion approving the two recommendations for revised SCR criteria.

  5. Concept Clearances (NIH Videocast  @02:00:30)
    1. Establishing Standards for Data and Metadata from Wearable Devices, Gregory Farber, Ph.D., Division of Data Science and Technology

      Dr. Farber talked about how quantitative data from wearable devices has the potential to provide information relevant to biomarkers of various diagnostic groups related to mental illness. However, there is a need for meaningful data standards and metadata to allow investigators to reuse data and make those data useful for analyses. This concept would support the development of initial data standards as well as further refinement as technology evolved.

      Discussion
      Discussants: Matthew Nock, Ph.D., and Rinad Beidas, Ph.D.
      Drs. Nock and Beidas expressed support for this concept and suggested that there be a range of interested parties (specifically end users) included in the creation of standards, as well as consideration for how to manage personally identifiable data and open data archives. Other Council members underscored the need to consider privacy, ethics, transparency, and public trust, as well as the need for strong academic-industry partnerships and device agnostic standards.

    2. Multimodal Artificial Intelligence: Opportunities and Challenges for HIV Clinical Care, Lori Scott-Sheldon, Ph.D., Division of AIDS Research

      Dr. Scott-Sheldon explained that the aim of this concept is to strengthen the development, adaptation, and use of accurate, safe, efficient, and unbiased artificial intelligence (AI) models to accelerate HIV diagnosis, prevention, and treatment. Cutting edge multimodal AI models have the potential to augment existing AI and machine learning approaches used in clinical care and promote targeted interventions.

      Discussion
      Discussants: Joseph Telfair, DrPH, M.P.H., and Jyotishman Pathak, Ph.D.
      Drs. Telfair and Pathak expressed support for this concept and commented on the need to define the term “multimodal,” proactively address potential misinformation about AI, consider privacy and security, and adopt ongoing feedback loops to assess models. Other Council members agreed that this concept should be human centered and suggested that implementation science was an important component to integrate. There were suggestions to measure uptake across various interested parties, consider the implementation burden on clinicians, and collaborate with industry to improve feasibility and uptake.

    3. Role of T Cells in HIV Central Nervous System Reservoir Seeding, Persistence, and Neuropathogenesis, Jeymohan Joseph, Ph.D., Division of AIDS Research

      Dr. Joseph described growing evidence that CD4+ T cells may be critical for HIV entry into the central nervous system (CNS). The aim of this concept is to define the mechanisms underlying the contribution of T cells to CNS reservoir seeding and neuropathogenesis using state-of-the-art methodologies, animal models, postmortem studies, and other novel immunologic approaches, as well as well as strategies to target CNS comorbidities.

      Discussion
      Discussants: Pamela Collins, M.D., M.P.H., and Olusola Ajilore, M.D., Ph.D
      Drs. Collins and Ajilore expressed support for this concept and suggested prioritizing the use of postmortem human tissue given the urgent need to better understand CNS neurotoxicity, particularly among the aging HIV population. Other Council members suggested population-level approaches to potentially identify uniform classification or characterize the extent that T cells impact the CNS.

  6. Comments from Retiring Members, Joseph Telfair, DrPH, M.P.H.; Hongkui Zeng, Ph.D. (NIH Videocast  @02:59:44)

    Dr. Gordon thanked Dr. Telfair and Hongkui Zeng, Ph.D., for their service to Council and invited them to comment on their experiences. Drs. Telfair and Zeng expressed appreciation for Council’s accomplishments and conveyed their suggestions for the way forward in mental health research.

  7. Adjournment

    Refer to Appendix D.

  8. Adjournment

    Dr. Gordon adjourned the open session of the meeting at 4:15 pm. 

    CLOSED PORTION OF THE MEETING

    The grant application review portion of the meeting was closed to the public in accordance with provisions as set forth in Section 552b(c)(4) and 552b(c)6. Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended.

    Tracy Waldeck, Ph.D., Executive Secretary of the Council, explained policies and procedures regarding confidentiality and conflict of interest to the members of the Council.

    Members absented themselves from the meeting during the discussion of and voting on applications from their own institutions, or other applications in which there was a potential conflict of interest, real or apparent. Members were asked to sign a statement to this effect.

Appendix A
DEPARTMENT OF HEALTH AND HUMAN SERVICES
NATIONAL INSTITUTES OF HEALTH
NATIONAL INSTITUTE OF MENTAL HEALTH
NATIONAL ADVISORY MENTAL HEALTH COUNCIL
(Terms end 9/30 of designated year)
CHAIRPERSON
Joshua A. Gordon, M.D., Ph.D.
Director
National Institute of Mental Health
Bethesda, MD
EXECUTIVE SECRETARY
Tracy Waldeck, Ph.D.
Director
Division of Extramural Activities
National Institute of Mental Health
Bethesda, MD
Members
Edwin G. Abel, III, Ph.D. (24)
Chair and Departmental Executive Officer
Department of Neuroscience and Pharmacology
Carver College of Medicine
University of Iowa
Iowa City, IA
Daniel H. Gillison, Jr. (25)
Chief Executive Officer
National Alliance on Mental Illness
Arlington, VA
Olusola Ajilore, M.D., Ph.D. (25)
Associate Professor
Director, Mood, and Anxiety Disorders Program
Department of Psychiatry
University of Illinois Chicago
Chicago, IL
Marguerita A. Lightfoot, Ph.D. (24)
Professor
Associate Dean for Research
OHSU-PSU School of Public Health
Portland, OR
Rinad S. Beidas, Ph.D. (26)
Ralph Seal Paffenberg Professor
Chair, Department of Medical Social Sciences
Feinberg School of Medicine
Northwestern University
Chicago, IL
Velma McBride Murry, Ph.D. (25)
Lois Autrey Betts Endowed Chair
Associate Provost, Office of Research and
Innovation
University Distinguished Professor
Departments of Health Policy
& Human and Organizational Development
Vanderbilt University
Nashville, TN
Pamela Y. Collins, M.D., M.P.H, (24)
Professor of Psychiatry and Behavioral Sciences
Professor of Global Health
Schools of Medicine and Public Health
University of Washington
Seattle, WA
Joel T. Nigg, Ph.D. (24)
Professor and Vice Chair for Psychology
Director, Center for ADHD Research
Department of Psychiatry
Oregon Health and Science University
Portland, OR
Matthew K. Nock, Ph.D. (24)
Edgar Pierce Professor of Psychology
Harvard College Professor
Chair, Department of Psychology
Harvard University
Cambridge, MA
Laura Scott, M.P.H., Ph.D. (25)
Research Professor
Department of Biostatics
University of Michigan
Ann Arbor, MI
Jyotishman Pathak, Ph.D. (26)
Frances & John L. Loeb Professor of Medical Informatics
Department of Population Health Sciences
Weill Cornell Medicine
Cornell University
New York City, NY
Joseph Telfair, Dr.P.H., M.P.H., (23)
Professor and Associate Dean
for Public Health Practice and Research
Karl E. Peace Distinguished Chair of Public Health
Fellow, Royal Society of Public Health
Jiann-Ping Hsu College of Public Health
Georgia Southern University
Statesboro, GA
Patricia R. Recupero, M.D., J.D. (24)
Senior Vice President of Education and Training
Care New England Butler Hospital
Providence, RI
Hongkui Zeng, Ph.D., (23)
Executive Vice President and Director
Allen Institute for Brain Science
Seattle, WA
Bryan L. Roth, M.D., Ph.D. (24)
Michael Hooker Distinguished Professor
Department of Pharmacology School of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC
 

EX OFFICIO MEMBERS

Office of the Secretary, DHHS
Xavier Becerra, J.D.
Secretary
Department of Health and Human Services
Washington, DC

National Institutes of Health
Lawrence A. Tabak, D.D.S., Ph.D.
Acting Director
National Institutes of Health
Bethesda, MD

Department of Veterans Affairs
Amy M. Kilbourne, Ph.D., M.P.H.
Director, Quality Enhancement Research Initiative (QUERI)
U.S. Department of Veterans Affairs
Professor of Learning Health Sciences
University of Michigan Medical School
Ann Arbor, MI

Liaison Representative
Anita Everett, M.D., DFAPA
Director
Center for Mental Health Services
US, HHS Substance Abuse and Mental Health Services
Rockville, MD

APPENDIX B
Department of Health and Human Services
Public Health Service
National Institutes of Health
National Advisory Mental Health Council
Summary of 272nd Meeting, January 29 and 30, 2024
Federal Staff Present in Person for Open Policy:

Evon Abisaid

Mary Acri

Lisa Alberts

Susannah Allison

Ruben Alvarez

Phyllis Ampofo

Patricia Areán

Paige Anderson   

Victoria Arango

Shelli Avenevoli

Frank Avenilla

Brian Barnett

Anita Bechtholt

Andrea Beckel-Mitchener

Iddil Bekirov

Yvonne Bennett

Lora Bingaman

Christina Borba

Susan Borja

Jasenka Borzan

Beth Bowers

Linda Brady

Andrew Breeden

Pim Brouwers

Sandy Buckingham

Marcy Burstein

Holly Campbell-Rosen

Mindy Chai

Sharon Chang

Zieta Charles

Mark Chavez

Eric Choi

Serena Chu

Jessenia Clary

Heather Coulter

Didi Cross

Leonardo Cubillos

Bruce Cuthbert

Debra Dabney 

Beshaun Davis

Julius Diggs

Jen Donahue

Jamie Driscoll

Sabiha Ethridge

Gregory Farber

Jelena Fay-Lukic

Katrina Ferrara

Beth Finch

Craig Fisher

Jansen Foster

Meredith Fox

Mike Freed

Stacia Friedman-Hill

Nick Gaiano

Karen Gavin-Evans

Rebecca Garcia

Marjorie Garvey

Lisa Gilotty

Christopher Gordon

Gregory Greenwood

Adam Haim

Katie Hamill

Wanda Harris-Lewis

Brittany Haynes

Robert Heinssen

Lauren Hill   

Mi Hillefors

Shuang-Bao Hu

Jennifer Humensky

Eliza Jacobs-Brichford

Daniel Janes

Terri Jarosik

Brittany Johnson

Andrew W. Jones

Jeymohan Joseph

Eugene Kane

Chris Kees

Eunyoung Kim

Megan Kinnane

Sandeep Kishore

Arina Knowlton

Susan Koester

Charisee Lamar

Sarah Leinwand

David Leitman

Tamara Lewis Johnson

Jane Lin

Ti Lin

Kelly Linthicum

Sarah Holly Lisanby

Allen Lo

Victor Lushin

Tianlu Ma

Annette Marrero-Oliveras

Nicole Martino

Julie Mason

Kristina Max

Juliette McClendon

Douglas Meinecke

Tatiana Meza-Cervera

Enrique Michelotti

Nicole Miko

David Miller

Ashley Moseley

Eric Murphy

Laurie Nadler

Stephen O’Connor

Anna E. Ordóñez

Nicolette O’Reilly

Claudio Ortiz

Christina Page

David Panchision

Jenni Pacheco

Emma Perez-Costas

Courtney Pinard

Suzy Pollard

Amanda Price

Vasudev Rao

Dianne Rausch

Sylvia Reeves

Syed Rizvi

Mary Rooney

Andrew Rossi

Laura Rowland

Matthew Rudorfer

Jonathan Sabbagh

Christopher Sarampote

Tanisha Savage

Aileen Schulte

Lori Scott-Sheldon

Natasha Sefcovic

Teri Senn

Pamela Shell 

Joel Sherrill

Lorie Shora

Galia Siegel

Todd Silber

Belinda Sims

Ashley Smith

Dawn Smith

Theresa Smith

Abigail Soyombo

Anaïs Stenson

Michael Stirratt

Maggie Sweeney

Alexander Talkovsky

Julie Thai

Laura Thomas

Ira Tigner, Jr. 

Jessica Tilghman

Leonardo Tonelli

Jing Tran

Farris Tuma

Justin Valenti

Ashlee Van’t Veer

Siavash Vaziri

Vidya Vedham

Aleksandra Vicentic

Matthew Vilnit

Clarissa B. Vincent

Andrea Wijtenburg

Kesi Williams

Abera Wouhib

Steven Zalcman

Julia Zehr

Others Present Virtually:
Deborah Krat, Webinar Support

Susan Funk, Webinar Support

Jerome Battle, NIH Videocast Specialist

Joy Jackson Farrar, NIH Videocast Specialist

Bob Hamer, NIH Videocast Specialist

Fran Kerrigan, NIH Videocast Specialist 
 

Appendix C
Staff Present Virtually for Closed Session:

Evon Abisaid

Mary Acri

Lisa Alberts

Susannah Allison

Ruben Alvarez

Phyllis Ampofo

Patricia Areán

Paige Anderson   

Victoria Arango

Shelli Avenevoli

Frank Avenilla

Brian Barnett

Anita Bechtholt

Andrea Beckel-Mitchener

Iddil Bekirov

Yvonne Bennett

Lora Bingaman

Christina Borba

Susan Borja

Jasenka Borzan

Beth Bowers

Linda Brady

Andrew Breeden

Pim Brouwers

Sandy Buckingham

Marcy Burstein

Holly Campbell-Rosen

Mindy Chai

Sharon Chang

Zieta Charles

Mark Chavez

Eric Choi

Serena Chu

Jessenia Clary

Heather Coulter

Didi Cross

Leonardo Cubillos

Bruce Cuthbert

Debra Dabney

Beshaun Davis

Julius Diggs

Jen Donahue

Jamie Driscoll

Sabiha Ethridge

Gregory Farber

Jelena Fay-Lukic

Katrina Ferrara

Beth Finch

Craig Fisher

Jansen Foster

Meredith Fox

Mike Freed

Stacia Friedman-Hill

Nick Gaiano

Karen Gavin-Evans

Rebecca Garcia

Marjorie Garvey

Lisa Gilotty

Christopher Gordon

Gregory Greenwood

Adam Haim

Katie Hamill

Wanda Harris-Lewis

Brittany Haynes

Robert Heinssen

Lauren Hill   

Mi Hillefors

Shuang-Bao Hu

Jennifer Humensky

Eliza Jacobs-Brichford

Daniel Janes

Terri Jarosik

Brittany Johnson

Andrew W. Jones

Jeymohan Joseph

Eugene Kane

Chris Kees

Eunyoung Kim

Megan Kinnane

Sandeep Kishore

Arina Knowlton

Susan Koester

Charisee Lamar

Sarah Leinwand

David Leitman

Tamara Lewis Johnson

Jane Lin

Ti Lin

Kelly Linthicum

Sarah Holly Lisanby

Allen Lo

Victor Lushin

Tianlu Ma

Annette Marrero-Oliveras

Nicole Martino

Julie Mason

Kristina Max

Juliette McClendon

Douglas Meinecke

Tatiana Meza-Cervera

Enrique Michelotti

Nicole Miko

David Miller

Ashley Moseley

Eric Murphy

Laurie Nadler

Stephen O’Connor

Anna E. Ordóñez

Nicolette O’Reilly

Claudio Ortiz

Christina Page

David Panchision

Jenni Pacheco

Emma Perez-Costas

Courtney Pinard

Suzy Pollard

Amanda Price

Vasudev Rao

Dianne Rausch

Sylvia Reeves

Syed Rizvi

Mary Rooney

Andrew Rossi

Laura Rowland

Matthew Rudorfer

Jonathan Sabbagh

Christopher Sarampote

Tanisha Savage

Aileen Schulte

Lori Scott-Sheldon

Natasha Sefcovic

Teri Senn

Pamela Shell

Joel Sherrill

Lorie Shora 

Galia Siegel

Todd Silber

Belinda Sims

Ashley Smith

Dawn Smith

Theresa Smith

Abigail Soyombo

Anaïs Stenson

Michael Stirratt

Maggie Sweeney

Alexander Talkovsky

Julie Thai

Laura Thomas

Ira Tigner, Jr.

Jessica Tilghman

Leonardo Tonelli

Jing Tran

Farris Tuma

Justin Valenti

Ashlee Van’t Veer

Siavash Vaziri

Vidya Vedham

Aleksandra Vicentic

Matthew Vilnit

Clarissa B. Vincent

Andrea Wijtenburg

Kesi Williams

Abera Wouhib

Steven Zalcman

Julia Zehr

References

1Ben-Zion Z, Spiller TR, Keynan JN, Admon R, Levy I, Liberzon I, Shalev AY, Hendler T, Harpaz-Rotem I. Evaluating the Evidence for Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma. Am J Psychiatry. 2023 Feb 1;180(2):146-154. doi: 10.1176/appi.ajp.20220271. Epub 2023 Jan 11. PMID: 36628514; PMCID: PMC9898083.

2Gaudiano BA, Ellenberg S, Johnson JE, Mueser KT, Miller IW. Effectiveness of acceptance and commitment therapy for inpatients with psychosis: Implementation feasibility and acceptability from a pilot randomized controlled trial. Schizophr Res. 2023 Nov;261:72-79. doi: 10.1016/j.schres.2023.09.017. Epub 2023 Sep 14. PMID: 37716204; PMCID: PMC10841307.

3Yarur, H.E., Casello, S.M., Tsai, V.S. et al. Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner. Mol Psychiatry (2023). https://doi.org/10.1038/s41380-023-02226-5